These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 36179876

  • 1. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
    Noya-Riobó MV, Miguel CÁ, Soriano DB, Brumovsky PR, Villar MJ, Coronel MF.
    Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
    [Abstract] [Full Text] [Related]

  • 2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 3. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N, Kostrzewa M, Makuch W, Pajak A, Kucharczyk M, Piscitelli F, Przewlocka B, Di Marzo V, Starowicz K.
    Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B, Fezza F, Parlongo G, Battista N, Sgro' E, Gasperi V, Zoccali C, Maccarrone M.
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [Abstract] [Full Text] [Related]

  • 6. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J, Charron S, Bouchard JF, Beaulieu P.
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [Abstract] [Full Text] [Related]

  • 7. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A, Okine BN, Finn DP, Masocha W.
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
    Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, Fernández-Ruiz J, Barrett DA, Kendall DA, Chapman V.
    Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
    [Abstract] [Full Text] [Related]

  • 11. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.
    Mitrirattanakul S, Ramakul N, Guerrero AV, Matsuka Y, Ono T, Iwase H, Mackie K, Faull KF, Spigelman I.
    Pain; 2006 Dec 15; 126(1-3):102-14. PubMed ID: 16844297
    [Abstract] [Full Text] [Related]

  • 12. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Sep 15; 330(3):902-10. PubMed ID: 19502530
    [Abstract] [Full Text] [Related]

  • 13. Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis.
    Mlost J, Kostrzewa M, Malek N, Starowicz K.
    Int J Mol Sci; 2018 Jan 24; 19(2):. PubMed ID: 29364174
    [Abstract] [Full Text] [Related]

  • 14. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
    Khasabova IA, Yao X, Paz J, Lewandowski CT, Lindberg AE, Coicou L, Burlakova N, Simone DA, Seybold VS.
    Pharmacol Res; 2014 Dec 24; 90():67-75. PubMed ID: 25304184
    [Abstract] [Full Text] [Related]

  • 15. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation.
    Sun L, Tai L, Qiu Q, Mitchell R, Fleetwood-Walker S, Joosten EA, Cheung CW.
    Eur J Pain; 2017 May 24; 21(5):804-814. PubMed ID: 28107590
    [Abstract] [Full Text] [Related]

  • 16. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM, Cioffi R, Viganò P, Candiani M, Verde R, Piscitelli F, Di Marzo V, Garavaglia E, Panina-Bordignon P.
    Reprod Sci; 2016 Aug 24; 23(8):1071-9. PubMed ID: 26887427
    [Abstract] [Full Text] [Related]

  • 17. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy.
    Barnes RC, Blanton H, Dancel CL, Castro-Piedras I, Rorabaugh BR, Morgan DJ, Guindon J.
    J Pharmacol Exp Ther; 2024 Oct 18; 391(2):258-271. PubMed ID: 38936979
    [Abstract] [Full Text] [Related]

  • 18. Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.
    Mulpuri Y, Marty VN, Munier JJ, Mackie K, Schmidt BL, Seltzman HH, Spigelman I.
    Neuropharmacology; 2018 Sep 01; 139():85-97. PubMed ID: 29981335
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.